{
    "title": "Drug duo Astrazeneca and Synairgen shares soar as they declare major breakthroughs in battle to develop Covid vaccine and treatment",
    "url": "https://www.dailymail.co.uk/money/markets/article-8541949/Drug-duo-Astrazeneca-Synairgen-soar-Covid-battle-intensifies.html",
    "date": "2020-07-20",
    "keywords": [
        "cent",
        "vaccine",
        "university",
        "coronavirus",
        "oxford",
        "synairgen",
        "record",
        "closing",
        "share",
        "drug",
        "soriot",
        "fund",
        "yesterday",
        "treatment",
        "astrazeneca",
        "stage",
        "stake",
        "virus",
        "system",
        "shot",
        "study",
        "boss",
        "risk",
        "trial",
        "disease",
        "investment",
        "account",
        "fee",
        "battle",
        "highsastrazeneca",
        "contract",
        "virusthe",
        "resultsafter",
        "today",
        "pension",
        "hong",
        "brummer",
        "health",
        "england",
        "fire",
        "article",
        "uk",
        "glaxosmithkline",
        "meanwhile",
        "maker",
        "key",
        "player",
        "race",
        "vaccinebut",
        "step",
        "azd1222",
        "version",
        "response",
        "journal",
        "author",
        "pollard",
        "immune",
        "period",
        "research",
        "covid19",
        "protection",
        "astra",
        "world",
        "approval",
        "company",
        "order",
        "price",
        "stock",
        "time",
        "market",
        "richard",
        "marsden",
        "executive",
        "sattar",
        "glasgow",
        "reduction",
        "severity",
        "gamechangerglaxo",
        "acquisition",
        "curevac",
        "diy",
        "capital",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}